Sign in
8-K

Current Report

Outlook Therapeutics, Inc. Filed Acc 0001104659-20-009271

Material agreement · Agreement ended · Unregistered share sale · Shareholder rights changed · Executive or director change · Other events

  • Item 1.01 Entry into a material definitive agreement
  • Item 1.02 Termination of a material definitive agreement
  • Item 3.02 Unregistered sales of equity securities
  • Item 3.03 Material modification to rights of security holders
  • Item 5.02 Departure or appointment of directors or officers
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading tm206289-1_8k.htm…